New radiotherapy technique could revolutionise cancer therapy
The Paul Scherrer Institute (PSI) has tested a new ultrafast, high-dose radiation technique using protons that scientists say could revolutionise cancer therapy and save patients many weeks of treatment.
This content was published on
2 minutes
Paul Scherrer Institute/sb
Español
es
Nueva radioterapia revolucionaría tratamiento del cáncer
Researchers at PSI’s Centre for Proton Therapy (CPT) in Villigen, northern Switzerland, are investigating whether a short, one-off, high-dose irradiation technique, known as FLASH, is also suitable for proton irradiation. It relies on a precise 3D radiation treatment developed at the institute called spot-scanningExternal link.
In a world first, PSI researchers, in collaboration with Lausanne University Hospital (CHUV), have tested the technique on a patient to treat a malignant skin tumour, the institute said in a statementExternal link on Monday.
With FLASH, a radiation dose rate of up to 1,000 gray per second is applied – around 100 times higher than in usual treatments. The test was approved by the Swiss Academy of Medical Sciences (SAMS).
During the trial the CHUV researchers used electron beams for the patient test, which are only suitable for very superficial tumours. In contrast, the protons used at PSI also reach tumours deep inside the body and can be stopped precisely at the site in the body where they should have their maximum effect on the cancer cells.
“If we can achieve the high precision and the good outcome of proton therapy with FLASH irradiation without damaging healthy tissue, this would be a huge step forward,” said CPT head and chief physician Damien Weber.
“If the principle works, the patients would only have to come for radiation treatment a few times, ideally only one to five times. The treatment appointments that open up as a result would be available to other cancer patients.”
More tests
Because of the extremely short irradiation, it is even possible to use the FLASH technique to treat tissue in the lungs, PSI said.
However, many years of technical development and tests are still needed before the process can be used regularly on patients, the institute added.
“But first and foremost, we need evidence that proton irradiation with the FLASH technique does not damage healthy body tissue,” said Weber.
New gel developed in Zurich renders alcohol harmless
This content was published on
A newly developed gel composed of whey proteins breaks down alcohol in the body and could reduce its harmful and intoxicating effects in humans.
Pro-Palestine protests extend to Basel and Fribourg universities
This content was published on
Demonstrators called for an academic boycott of all Israeli institutions and disassociation with Chaim Weizmann, the first Israeli president.
This content was published on
In many cases, China's use of AI undermines the national security of the US and its allies, according to a US government representative.
Swiss Hells Angels trial alleges rape and money laundering
This content was published on
An allegedly high-ranking member of the Hells Angels is accused of money laundering totalling millions and rape, among other serious crimes.
SWISS is airline ‘group flagship’ says Lufthansa boss
This content was published on
Despite challenges, Lufthansa and its most important subsidiary, Swiss International Airlines, promise increased satisfaction and continued growth.
Swiss rediscover communist zeal after 84-year hiatus
This content was published on
Over 300 participants founded the Revolutionary Communist Party (RKP) at its congress in Burgdorf in canton Bern at the weekend.
This content was published on
Nemo brought the Eurovision Song Contest to Switzerland with a victory on Saturday evening in Malmö, Sweden. It is Switzerland's third victory in the history of the music contest.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Precision Medicine: A game changer for brain and mental health
This content was published on
Cancer patients benefit from precision medicine, but we must invest in a personalised approach to treating neurological disease such as Alzheimer’s.
Swiss researchers decode cell receptor in cancer metastasis
This content was published on
Researchers in Switzerland have deciphered the structure of a cell receptor, unlocking new hope for the prevention of metastasis of certain cancers.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.